BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 12940508)

  • 1. Tryptophan metabolites and brain disorders.
    Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
    Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous neurotoxins from tryptophan.
    Stone TW
    Toxicon; 2001 Jan; 39(1):61-73. PubMed ID: 10936623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.
    Stone TW
    Prog Neurobiol; 2001 Jun; 64(2):185-218. PubMed ID: 11240212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.
    Schwarcz R; Pellicciari R
    J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
    Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
    J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan, adenosine, neurodegeneration and neuroprotection.
    Stone TW; Forrest CM; Mackay GM; Stoy N; Darlington LG
    Metab Brain Dis; 2007 Dec; 22(3-4):337-52. PubMed ID: 17712616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.
    Moroni F
    Eur J Pharmacol; 1999 Jun; 375(1-3):87-100. PubMed ID: 10443567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An expanding range of targets for kynurenine metabolites of tryptophan.
    Stone TW; Stoy N; Darlington LG
    Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central kynurenine pathway shift with age in women.
    de Bie J; Guest J; Guillemin GJ; Grant R
    J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; VĂ©csei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.
    Beal MF; Matson WR; Swartz KJ; Gamache PH; Bird ED
    J Neurochem; 1990 Oct; 55(4):1327-39. PubMed ID: 2144582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
    Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
    J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of kynurenines in the production of neuronal death, and the neuroprotective effect of purines.
    Stone TW; Behan WM; Jones PA; Darlington LG; Smith RA
    J Alzheimers Dis; 2001 Aug; 3(4):355-366. PubMed ID: 12214038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
    Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
    Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan metabolism in the central nervous system: medical implications.
    Ruddick JP; Evans AK; Nutt DJ; Lightman SL; Rook GA; Lowry CA
    Expert Rev Mol Med; 2006 Aug; 8(20):1-27. PubMed ID: 16942634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].
    Saito K
    Rinsho Byori; 1995 Sep; 43(9):891-901. PubMed ID: 7474452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.